PD01.06 CANOPY-2: Phase 3 Study of Canakinumab Plus Docetaxel as Second/Third Line Therapy in Locally Advanced/Metastatic NSCLC
| Autor: | Papadimitrakopoulou, V.A., Goto, Y., Lim, D.W.T., Mookerjee, B., Malet, I., Zhu, Z., Reck, M., Paz-Ares, L. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology November 2019 14(11) Supplement 1:S1136-S1136 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|